ScholarWorks@SUNGKYUNKWAN UNIVERSITY: KIM, TAE KYU

Detailed Information

KIM, TAE KYU (김태규)

Medicine (Medicine)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

prognosis:6||Nonsmall cell lung cancer:4||Adjuvant radiotherapy:4||Breast cancer:4||Gallbladder cancer:3||immunohistochemistry:3||Chemoradiotherapy:3||Immunohistochemistry:3||Lymphatic irradiation:3||chemoradiotherapy:3||PI3K:2||Rectal neoplasms:2||videoassisted thoracoscopic surgery:2||Locoregional neoplasm recurrences:2||Lymph node:2||Radiation effects:2||Prognosis:2||HSP90:2||GRP94:2||Leukopenia:2||pulmonary nodule:2||radiation therapy:2||p4EBP1:2||Radiation therapy:2||TRAP1:2||Local recurrence:1||Locoregional recurrence:1||Lymph nodes:1||Morbidity:1||Nasopharyngeal carcinoma:1||Neoadjuvant:1||Neoadjuvant chemotherapy:1||Nonsmall cell lung carcinoma:1||Parotid gland cancers:1||Parotidectomy:1||Postmastectomy radiation therapy:1||Primary systemic therapy:1||Proctitis:1||Prognostic factor:1||Prognostic factors:1||Prostate cancer:1||Radiation dose hypofractionation:1||Radiotherapy:1||Radiotherapy planning:1||Randomized trial:1||Recurrence:1||Resection margin:1||Residual nodal disease:1||Salivary gland cancer:1||Salvage concurrent chemoradiation therapy:1||Sentinel lymph node biopsy:1||Simultaneous integrated boost:1||Small cell lung cancer:1||Spinal metastases:1||Stents:1||Stereotactic body radiotherapy:1||Survival:1||Therapeutic target:1||Treatment strategy:1||Wholebrain radiation therapy:1||adjuvant treatment:1||aged:1||anisotropic analytical algorithm (AAA):1||baseline shifts:1||biomarker:1||calcitonin:1||chemotherapy:1||computed tomography multiplanar reconstruction:1||esophageal cancer:1||esophageal squamous cell carcinoma:1||fluoroscopy:1||glioblastoma:1||hepatocellular carcinoma:1||hypofractionation:1||intensity modulated radiation therapy (IMRT):1||intermediate dose calculation:1||leptomeningeal enhancement:1||localization:1||locoregional recurrencefree survival:1||medullary carcinoma:1||overall survival:1||p110 alpha:1||p110 beta:1||p110γ:1||parasympathetic innervation:1||percutaneous transhepatic biliary drainage:1||perihilar:1||prophylactic cranial irradiation:1||radiotherapy:1||rectal neoplasm:1||recurrence:1||respiratorygated radiotherapy:1||salivary gland:1||smallcell lung cancer:1||stent:1||stomach:1||surgery:1||surplus solid angle:1||wedge resection:1||wire:1||xerostomia:1||Age:1||Alpha lipoic acid:1||AntiHER2 targeted therapy:1||Anticoagulants:1||Arteries:1||Axillary lymph node dissection:1||Bile duct neoplasms:1||Biomarkers:1||Breast reconstruction:1||Bypass:1||Cholangiocarcinoma:1||Clinically nodenegative:1||Coil:1||Colorectal cancer:1||Extrahepatic bile duct cancer:1||Graft:1||HER2positive breast cancer:1||Hepatocellular carcinoma:1||Hippocampus:1||HoravaLifsbitz gravity:1||HyperArc:1||Intermediate grade:1||Isoform:1||Liver cirrhosis:1||

STATISTICS: Total View :5,387,116; Today View :3,574

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE